CRNX
Price
$42.86
Change
+$0.89 (+2.12%)
Updated
Nov 21 closing price
Capitalization
4.07B
100 days until earnings call
Intraday BUY SELL Signals
ROIV
Price
$20.22
Change
-$0.05 (-0.25%)
Updated
Nov 21 closing price
Capitalization
14.06B
84 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRNX vs ROIV

Header iconCRNX vs ROIV Comparison
Open Charts CRNX vs ROIVBanner chart's image
Crinetics Pharmaceuticals
Price$42.86
Change+$0.89 (+2.12%)
Volume$1.33M
Capitalization4.07B
Roivant Sciences
Price$20.22
Change-$0.05 (-0.25%)
Volume$4.21M
Capitalization14.06B
CRNX vs ROIV Comparison Chart in %
CRNX
Daily Signal:
Gain/Loss:
ROIV
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRNX vs. ROIV commentary
Nov 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and ROIV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 24, 2025
Stock price -- (CRNX: $42.86 vs. ROIV: $20.22)
Brand notoriety: CRNX and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 75% vs. ROIV: 51%
Market capitalization -- CRNX: $4.07B vs. ROIV: $14.06B
CRNX [@Biotechnology] is valued at $4.07B. ROIV’s [@Biotechnology] market capitalization is $14.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRNX and ROIV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 2 TA indicator(s) are bullish while ROIV’s TA Score has 2 bullish TA indicator(s).

  • CRNX’s TA Score: 2 bullish, 3 bearish.
  • ROIV’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than ROIV.

Price Growth

CRNX (@Biotechnology) experienced а +0.45% price change this week, while ROIV (@Biotechnology) price change was -0.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +62.87%.

Reported Earning Dates

CRNX is expected to report earnings on Mar 04, 2026.

ROIV is expected to report earnings on Feb 16, 2026.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($14.1B) has a higher market cap than CRNX($4.07B). ROIV YTD gains are higher at: 70.921 vs. CRNX (-16.174). CRNX has higher annual earnings (EBITDA): -419.62M vs. ROIV (-1.18B). ROIV has more cash in the bank: 4.5B vs. CRNX (1.2B). CRNX has less debt than ROIV: CRNX (49.9M) vs ROIV (99.7M). ROIV has higher revenues than CRNX: ROIV (23.2M) vs CRNX (1.39M).
CRNXROIVCRNX / ROIV
Capitalization4.07B14.1B29%
EBITDA-419.62M-1.18B36%
Gain YTD-16.17470.921-23%
P/E RatioN/A1.97-
Revenue1.39M23.2M6%
Total Cash1.2B4.5B27%
Total Debt49.9M99.7M50%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
50
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXROIV
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
69%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
70%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
66%
Advances
ODDS (%)
Bullish Trend 8 days ago
74%
Bullish Trend 15 days ago
72%
Declines
ODDS (%)
Bearish Trend 5 days ago
76%
Bearish Trend 4 days ago
69%
BollingerBands
ODDS (%)
N/A
Bearish Trend 6 days ago
55%
Aroon
ODDS (%)
Bearish Trend 4 days ago
68%
Bullish Trend 4 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signal:
Gain/Loss:
ROIV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HCMAX29.540.67
+2.32%
Hillman Value
HIMVX28.620.65
+2.32%
Harbor Mid Cap Value Investor
GSMCX38.400.84
+2.24%
Goldman Sachs Mid Cap Value Instl
FGDAX49.360.32
+0.65%
Fidelity Advisor Gold A
MFEHX192.900.90
+0.47%
MFS Growth R3